glycerylphosphorylcholine has been researched along with tanespimycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandes, AH; Ronen, SM; Ward, CS | 1 |
| Arunan, V; Beloueche-Babari, M; Jackson, LE; Leach, MO; Perusinghe, N; Sharp, SY; Workman, P | 1 |
2 other study(ies) available for glycerylphosphorylcholine and tanespimycin
| Article | Year |
|---|---|
17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Topics: Antigens, CD; Antineoplastic Agents; Benzoquinones; Biological Transport; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Choline; Female; Gene Expression Regulation, Neoplastic; Glycerylphosphorylcholine; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Magnetic Resonance Spectroscopy; MCF-7 Cells; Membrane Transport Proteins; Organic Cation Transport Proteins; Phospholipases A2; Phosphorylcholine | 2010 |
Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition.
Topics: Antineoplastic Agents; Benzoquinones; Biomarkers, Pharmacological; Glycerylphosphorylcholine; Heterocyclic Compounds, 2-Ring; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Lipid Metabolism; Magnetic Resonance Spectroscopy; Melanoma; Mutation; Naphthalenes; Phospholipase A2 Inhibitors; Proto-Oncogene Proteins B-raf; Pyrazoles; Pyrones; Skin Neoplasms | 2010 |